Skip to main content
. 2026 Feb 9;14(2):161. doi: 10.3390/vaccines14020161
sIPV Sabin strain–based inactivated poliovirus vaccine
IPV Inactivated poliovirus vaccine
OPV Oral poliovirus vaccine
DTaP Diphtheria–tetanus–acellular pertussis vaccine
DT Diphtheria–tetanus vaccine
Hib Haemophilus influenzae type b vaccine
MMR Measles–mumps–rubella vaccine
BCG Bacille Calmette–Guérin vaccine
EV71 Enterovirus 71 vaccine
VAPP Vaccine-associated paralytic poliomyelitis
VDPV Vaccine-derived poliovirus
AEFI Adverse events following immunization
CNAEFIS China National Adverse Events Following Immunization Surveillance System
WHO World Health Organization
GPEI Global Polio Eradication Initiative
RR Relative risk
aRR Adjusted rate ratio
CI Confidence interval
NB Negative binomial (regression)
NHC National Health Commission of China
NMPA National Medical Products Administration
CDC Center for Disease Control and Prevention